STOCK TITAN

Global Hemp Group Inc - GBHPF STOCK NEWS

Welcome to our dedicated page for Global Hemp Group news (Ticker: GBHPF), a resource for investors and traders seeking the latest updates and insights on Global Hemp Group stock.

Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) is a dynamic company focused on Industrial Hemp and Biopharma. The Industrial Hemp division emphasizes environmental uses of hemp for construction and sustainable bio-energy sources, with a focus on developing Intellectual Property. The Health and Wellness Division acquires exclusive patents and IP, notably from Apollon Formularies plc. and B-Organic R&D Corp., specializing in cancer treatments from natural biologics, cannabinoids, terpenes, flavonoids, and mushroom extracts. These strategic alliances drive innovative ventures in the commercial biopharma sector.

Rhea-AI Summary
Global Hemp Group Inc. has executed an Exclusive Option Agreement to acquire Serres Thériault (2021) Inc., a vertically integrated cannabis operator in New Brunswick. This transaction will diversify the company's activities and provide access to licenses from Health Canada, furthering its R&D ambitions for its Health and Wellness division.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Global Hemp Group Inc. (CSE:GHG, OTC:GBHPF) announced the addition of Gabriel Gauthier, a pioneer in hemp construction, to its team. Gauthier will advise on hemp building applications for the Colorado Hemp Agro-Industrial Zone project in Colorado, which aims to cultivate industrial hemp and generate multiple revenue streams. The company also completed an acquisition, issuing 12,386,675 shares to Marijuana Company of America Inc. at $0.02 each. GHG focuses on establishing a strong presence in the U.S. hemp industry and developing value-added products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
none
-
Rhea-AI Summary

Global Hemp Group Inc. (CSE:GHG, OTC:GBHPF) has announced its acquisition of a 50% stake in the Oregon Hemp Project from Marijuana Company of America Inc. The deal involves an upfront payment of $210,000 and additional stock valued at $185,000. This acquisition will allow Global Hemp to fully consolidate the 109-acre Scio, Oregon farm into its financial statements, enhancing control over its operations. Additionally, GHG received short-term loans totaling C$50,000, resulting in the issuance of 1,700,000 common shares as a bonus to lenders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.81%
Tags
Rhea-AI Summary

Global Hemp Group Inc. (CSE: GHG / OTC: GBHPF) has announced the appointment of Prof. Victor Castaño, Ph.D. as the Head of its new Research and Development Division. Prof. Castaño brings extensive experience in materials science and biomedicine with over 30 years in developing sustainable construction materials, nanofertilizers, and enhanced extraction methods from hemp. The R&D division will focus on environmentally-friendly construction materials, innovative nanofertilizers, and advanced extraction techniques, aiming to create marketable, patented technologies for the hemp industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
-
Rhea-AI Summary

Global Hemp Group Inc. (CSE:GHG)(OTC:GBHPF) has announced a 50/50 strategic partnership with Western Sierra Resource Corporation to establish a Sustainable Economic Zone in northwest Colorado. This initiative aims to leverage WSRC's $40 million water infrastructure for vertical integration in hemp cultivation and processing. The project will create a Hemp Agro-Industrial Zone (HAIZ) focusing on affordable housing and value-added hemp products. An initial funding commitment of $25,000 is set within the next 30 days, with definitive agreements expected in 60 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.09%
Tags
partnership
-
Rhea-AI Summary

Global Hemp Group Inc. (CSE:GHG, OTC:GBHPF) announced a rights offering for common shareholders, effective July 31, 2020. Shareholders of record as of August 4, 2020, will receive rights to subscribe for units. Trading of the rights began on August 10, 2020, under the symbol GHG.RT, but faced a temporary halt due to a system glitch. This issue has now been resolved, and trading is set to resume on August 13, 2020. Full details are available in the Rights Offering circular filed on SEDAR.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Global Hemp Group (GBHPF)?

The current stock price of Global Hemp Group (GBHPF) is $0.01 as of February 27, 2025.

What is the market cap of Global Hemp Group (GBHPF)?

The market cap of Global Hemp Group (GBHPF) is approximately 561.1K.

What is Global Hemp Group Inc. focused on?

Global Hemp Group Inc. is currently focused on Industrial Hemp and Biopharma, emphasizing environmental uses of hemp for construction and sustainable bio-energy sources, as well as acquiring exclusive patents and IP in the Health and Wellness Division.

What are the primary areas of interest for the Industrial Hemp division?

The primary focus of the Industrial Hemp division includes environmental uses of hemp for construction and sustainable bio-energy sources, contributing to a carbon-negative footprint, and developing Intellectual Property.

What strategic alliances has Global Hemp Group Inc. entered into?

Global Hemp Group Inc. has entered into strategic alliances with Apollon Formularies plc. and B-Organic R&D Corp., acquiring exclusive patents and IP specializing in cancer treatments from natural biologics, cannabinoids, terpenes, flavonoids, and mushroom extracts.

What drives Global Hemp Group Inc.'s innovative ventures in the biopharma sector?

Global Hemp Group Inc.'s strategic alliances with Apollon Formularies plc. and B-Organic R&D Corp. drive innovative ventures in the commercial biopharma sector, focusing on developing pre-clinically tested formulations for cancer treatments and enhancing solubility and bioavailability of various pharma ingredients.

What is the significance of the exclusive patents and IP acquired by Global Hemp Group Inc.?

The exclusive patents and IP acquired by Global Hemp Group Inc. from Apollon Formularies plc. and B-Organic R&D Corp. contribute to cutting-edge innovation in cancer treatments from natural biologics, cannabinoids, terpenes, flavonoids, and mushroom extracts, emphasizing the company's commitment to the commercial biopharma sector.
Global Hemp Group Inc

OTC:GBHPF

GBHPF Rankings

GBHPF Stock Data

561.13k
32.54M
9.63%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
North Vancouver